Filtros de búsqueda

Lista de obras de Marc Ychou

A Prospective Randomized Study Comparing High- and Low-Dose Leucovorin Combined With Same-Dose 5-Fluorouracil in Advanced Colorectal Cancer ⬇️

artículo científico publicado el 1 de junio de 1998

A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer

artículo científico

A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer.

artículo científico publicado en 2010

A phase II study of 5-fluorouracil, leucovorin and cisplatin (FLP) for metastatic gastric cancer

artículo científico publicado en 1996

A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802).

artículo científico publicado en 2009

A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma.

artículo científico publicado en 2002

A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a

artículo científico publicado en 2007

A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.

artículo científico publicado en 2013

ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases.

artículo científico publicado en 2004

Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours.

artículo científico publicado en 2004

Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801).

artículo científico publicado en 2005

Adjuvant radioimmunotherapy trial with iodine-131-labeled anti-carcinoembryonic antigen monoclonal antibody F6 F(ab')2 after resection of liver metastases from colorectal cancer

artículo científico publicado en 2008

Alternative bimonthly cycles of doxorubicin, cyclophosphamide, and etoposide, cisplatin with hematopoietic growth factor support in patients with carcinoma of unknown primary site.

artículo científico publicado en 2002

An assessment of the benefit-risk balance of FOLFIRINOX in metastatic pancreatic adenocarcinoma

artículo científico publicado en 2016

An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors.

artículo científico publicado en 2003

An unusual liver metastasis

artículo científico publicado en 2006

Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer.

artículo científico publicado en 2009

Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial

artículo científico

Antibody targeting of claudin-1 as a potential colorectal cancer therapy.

artículo científico publicado en 2017

Assessment of epidermal growth factor receptor (EGFR) expression in primary colorectal carcinomas and their related metastases on tissue sections and tissue microarray

artículo científico publicado en 2006

Assessment of liver metastases from colorectal adenocarcinoma following chemotherapy: SPIO-MRI versus FDG-PET/CT.

artículo científico publicado en 2010

Bevacizumab Combined With Chemotherapy in the Second-Line Treatment of Metastatic Colorectal Cancer: Results from the Phase II BEVACOLOR Study ⬇️

artículo científico publicado el 29 de julio de 2011

Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study

artículo científico publicado en 2009

Bone metastases in gastrointestinal cancer

scientific article published on 09 November 2014

Cancer of the stomach

artículo científico publicado en 2006

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer

artículo científico publicado en 2011

Cetuximab Plus FOLFIRINOX (ERBIRINOX) as First-Line Treatment for Unresectable Metastatic Colorectal Cancer: A Phase II Trial ⬇️

artículo científico publicado el 20 de octubre de 2011

Chemotherapy in carcinomas of unknown primary site: a high-dose intensity policy.

artículo científico publicado en 1999

Circadian rhythm of 5-fluorouracil population pharmacokinetics in patients with metastatic colorectal cancer.

artículo científico publicado en 1999

Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.

artículo científico publicado en 2013

Circulating DNA Demonstrates Convergent Evolution and Common Resistance Mechanisms during Treatment of Colorectal Cancer.

artículo científico publicado en 2017

Circulating DNA as a Strong Multimarker Prognostic Tool for Metastatic Colorectal Cancer Patient Management Care

artículo científico publicado en 2016

Clinical impact of intesified 5-Fluorouracil-based chemotherapy using a prospective pharmacokinetically-guided dosing approach: comparative study in elderly and non-elderly patients with metastatic colorectal cancer.

artículo científico publicado en 2010

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment.

artículo científico publicado en 2017

Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA.

artículo científico publicado en 2014

Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301).

artículo científico publicado en 2010

Combined radiotherapy, 5-fluorouracil continuous infusion and weekly oxaliplatin in advanced rectal cancer: a phase I study.

artículo científico publicado en 2005

Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab.

artículo científico publicado en 2017

Conservative surgery for low rectal carcinoma after high-dose radiation. Functional and oncologic results

scientific article published on 01 January 1995

Cost consequences of adjuvant capecitabine, Mayo Clinic and de Gramont regimens for stage III colon cancer in the French setting.

artículo científico publicado en 2007

Cost-Minimisation Analysis in First-Line Treatment of Metastatic Colorectal Cancer in France: XELOX versus FOLFOX-6 ⬇️

artículo científico publicado el 1 de enero de 2010

Cutaneous adverse reactions of EGFR (epidermal growth factor receptor)-inhibitors: therapeutic algorithm of the French PROCUR group

artículo científico publicado en 2013

Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancer

artículo científico publicado en 2007

Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.

artículo científico publicado en 1996

Detection of lymph node metastases in lung cancer: comparison of 131I-anti-CEA-anti-CA 19-9 immunoscintigraphy versus computed tomography

artículo científico publicado en 1994

Differences in coagulability of three glutaraldehyde solutions in the glutaraldehyde test on bovine whole blood

artículo científico publicado en 1985

Docetaxel and Radiotherapy and Pancreatic Cancer ⬇️

artículo científico publicado el 1 de octubre de 2003

Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survival.

artículo científico publicado en 2011

Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer.

artículo científico publicado en 2017

Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the "THERAPY"phase 1-2 trial

artículo científico publicado en 2015

EGFR and HER3 mRNA expression levels predict distant metastases in locally advanced rectal cancer ⬇️

artículo científico publicado el 26 de octubre de 2010

Effect of Single Nucleotide Polymorphisms in the Xenobiotic-sensing Receptors NR1I2 and NR1I3 on the Pharmacokinetics and Toxicity of Irinotecan in Colorectal Cancer Patients

artículo científico publicado en 2016

Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: final results from a randomised phase II study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus be

artículo científico publicado en 2013

Efficacy of combined 5-fluorouracil and cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis

artículo científico publicado en 1994

Efficacy of irinotecan in combination with 5-fluorouracil (FOLFIRI) for metastatic gastric or gastroesophageal junction adenocarcinomas (MGA) treatment

scientific article published on 01 January 2011

Efficacy of prolonged-release somatostatin analog monotherapy in metastatic endocrine tumors

artículo científico publicado en 2008

Efficacy of prophylactic anti-diarrhoeal treatment in patients receiving Campto for advanced colorectal cancer.

artículo científico publicado en 2002

Enhancement of radiation therapy by tumor necrosis factor alpha in human colon cancer using a bispecific antibody.

artículo científico publicado en 2003

Estimating optimal dose of twice-weekly gemcitabine for concurrent chemoradiotherapy in unresectable pancreatic carcinoma: mature results of GEMRT-01 Phase I trial

artículo científico publicado en 2010

FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, rando

artículo científico publicado en 2014

FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, rando

artículo científico publicado en 2015

Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer

artículo científico publicado en 2015

Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX

artículo científico publicado en 2011

Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial

artículo científico publicado en 2006

Folliculitis Induced by EGFR Inhibitors, Preventive and Curative Efficacy of Tetracyclines in the Management and Incidence Rates According to the Type of EGFR Inhibitor Administered: A Systematic Literature Review ⬇️

artículo científico publicado el 16 de marzo de 2012

Four-step high-dose sequential chemotherapy with hematopoietic progenitor-cell support as induction treatment for patients with solid tumors

artículo científico publicado en 1997

Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers

artículo científico publicado en 2004

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.

artículo científico publicado en 2006

Gemcitabine and docetaxel after failure of cisplatin-based chemotherapy in patients with carcinoma of unknown primary site.

artículo científico publicado en 2003

Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site.

artículo científico publicado en 2004

Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients.

artículo científico publicado en 1993

Hepatic arterial infusion using pirarubicin combined with systemic chemotherapy: a phase II study in patients with nonresectable liver metastases from colorectal cancer.

artículo científico publicado en 2003

Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.

artículo científico publicado en 2005

High fragmentation characterizes tumour-derived circulating DNA.

artículo científico publicado en 2011

Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.

artículo científico

Imaged-guided liver stereotactic body radiotherapy using VMAT and real-time adaptive tumor gating. Concerns about technique and preliminary clinical results.

artículo científico publicado en 2016

Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial

artículo científico publicado en 2012

Impact of Fc{gamma}RIIa-Fc{gamma}RIIIa polymorphisms and KRAS mutations on the clinical outcome of patients with metastatic colorectal cancer treated with cetuximab plus irinotecan.

artículo científico publicado en 2009

Impact of RNA degradation on gene expression profiles: assessment of different methods to reliably determine RNA quality

artículo científico publicado en 2006

Impact of mutational status of KRAS in the care of patients with colorectal cancer metastasis

artículo científico publicado en 2009

Individual 5FU-dose adaptation schedule using bimonthly pharmacokinetically modulated LV5FU2 regimen: a feasibility study in patients with advanced colorectal cancer

scientific article published on 01 May 1999

Initial endoscopic description of esophageal squamous cell carcinomas

artículo científico publicado en 2006

Inter-observer agreement between dermatologists and oncologists in assessing dermatological toxicities in patients with metastatic colorectal cancer treated by cetuximab-based chemotherapies: a pilot comparative study.

artículo científico publicado en 2010

Intra-operative radiotherapy of rectal cancer: results of the French multi-institutional randomized study

scientific article published on 19 February 2011

Introduction

artículo científico publicado en 2015

Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental model

artículo científico publicado en 1999

Irinotecan combined with bolus fluorouracil, continuous infusion fluorouracil, and high-dose leucovorin every two weeks (LV5FU2 regimen): a clinical dose-finding and pharmacokinetic study in patients with pretreated metastatic colorectal cancer

artículo científico publicado en 1999

Is neoadjuvant treatment necessary in resectable cancers of the cardia?

artículo científico publicado el 1 de octubre de 1997

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

artículo científico publicado en 2008

Le site de référence du Partenariat européen d’innovation pour un vieillissement actif et en bonne santé MACVIA-LR (contre les maladies chroniques pour un vieillissement en bonne santé en Languedoc-Roussillon)

artículo científico publicado en 2015

Letter to the Editor

artículo científico publicado en 2002

MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy Ageing

artículo científico publicado en 2016

MR volumetric measurement of low rectal cancer helps predict tumor response and outcome after combined chemotherapy and radiation therapy

artículo científico publicado en 2012

Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm.

artículo científico publicado en 2012

Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies.

artículo científico publicado en 2017

Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients.

artículo científico publicado en 2002

Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer

artículo científico publicado en 2006

Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR.

artículo científico publicado en 2017

Neoadjuvant chemoradiotherapy in esophageal cancer: is it still the question?

artículo científico publicado en 2008

Neoadjuvant chemotherapy in locally advanced gastric carcinoma--a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinum

scientific article published on 01 January 1994

Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.

artículo científico publicado en 2010

Neoadjuvant therapy for gastroesophageal adenocarcinoma

artículo científico publicado en 2016

Neoadjuvant treatment in upper gastrointestinal adenocarcinomas: new paradigms from old concepts?

artículo científico publicado en 2007

PD-012Analysis of patients ≥75 years in the open-label phase 3b CONSIGN trial of regorafenib in previously treated metastatic colorectal cancer (mCRC).

artículo científico publicado en 2016

Pharmacokinetics and pharmacodynamics of irinotecan and its metabolites from plasma and saliva data in patients with metastatic digestive cancer receiving Folfiri regimen.

artículo científico publicado en 2005

Pharmacokinetics of 5-fluorouracil (5-FUra) in patients with metastatic colorectal cancer receiving 5-FUra bolus plus continuous infusion with high dose folinic acid (LV5FU2)

scientific article published on 01 July 1997

Phase I trial of oxaliplatin with fluorouracil, folinic acid and concurrent radiotherapy for oesophageal cancer.

artículo científico publicado en 2008

Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers.

artículo científico publicado en 1998

Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer

scientific article published on 01 February 1998

Postoperative irinotecan in resected stage II-III rectal cancer: final analysis of the French R98 Intergroup trial†.

artículo científico publicado en 2015

Potential contribution of 131I-labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: pretherapeutic study with dose recovery in resected tissues

artículo científico publicado en 1993

Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer.

artículo científico publicado en 2003

Predictors of overall and recurrence-free survival after neoadjuvant chemotherapy for gastroesophageal adenocarcinoma: Pooled analysis of individual patient data (IPD) from randomized controlled trials (RCTs).

artículo científico publicado en 2017

Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data

artículo científico publicado en 2013

Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review.

artículo científico publicado en 2009

Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer

artículo científico publicado en 2005

Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestiv

artículo científico publicado en 2014

Quantification of HER expression and dimerization in patients' tumor samples using time-resolved Förster resonance energy transfer

artículo científico publicado en 2012

RIP140 increases APC expression and controls intestinal homeostasis and tumorigenesis.

artículo científico publicado en 2014

Radioimmunotherapy of colon carcinoma with I-131 labeled antibodies, successful experimental results and clinical dosimetry study

scientific article published on 01 October 1990

Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study).

artículo científico publicado en 2016

Randomized comparison of prophylactic antidiarrheal treatment versus no prophylactic antidiarrheal treatment in patients receiving CPT-11 (irinotecan) for advanced 5-FU-resistant colorectal cancer: an open-label multicenter phase II study

artículo científico publicado en 2000

Relationship of serum bilirubin to toxicity in patients with metastatic colorectal cancer treated with single-agent high-dose irinotecan.

artículo científico publicado en 2005

Reply to E.C. Smyth et al and E. Elimova et al.

artículo científico publicado en 2015

Reproductive Decision-Making in MMR Mutation Carriers After Results Disclosure: Impact of Psychological Status in Childbearing Options.

artículo científico publicado en 2015

Retrospective Analysis of CA19-9 Decrease in Patients with Metastatic Pancreatic Carcinoma Treated with FOLFIRINOX or Gemcitabine in a Randomized Phase III Study (ACCORD11/PRODIGE4).

artículo científico publicado en 2017

Reverse transcription-quantitative polymerase chain reaction: description of a RIN-based algorithm for accurate data normalization

artículo científico publicado en 2009

SBRT planning for liver metastases: A focus on immobilization, motion management and planning imaging techniques.

artículo científico publicado en 2017

SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling.

artículo científico publicado en 2016

Safety of cisplatin combined with continuous 5-FU versus bolus 5-FU and leucovorin, in metastatic gastrointestinal cancer (FFCD 9404 randomised trial).

artículo científico publicado en 2006

Sensitive HPLC-Fluorescence Method for Irinotecan and Four Major Metabolites in Human Plasma and Saliva: Application to Pharmacokinetic Studies ⬇️

artículo científico publicado el 1 de noviembre de 2003

Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II study

artículo científico publicado en 1997

Small cell carcinoma with concomitant adenocarcinoma arising in a Barrett's oesophagus: report of a case with a favourable behaviour

artículo científico publicado en 2007

Sorafenib overcomes irinotecan resistance in colorectal cancer by inhibiting the ABCG2 drug-efflux pump.

artículo científico publicado en 2013

Specific extracellular matrix remodeling signature of colon hepatic metastases

artículo científico publicado en 2013

Surgery for esophageal cancer after concomitant radiochemotherapy: oncologic and functional results

artículo científico publicado en 2005

Survey on the management of skin toxicity associated with EGFR inhibitors amongst French physicians.

artículo científico publicado en 2012

Targeting the Wnt Pathway and Cancer Stem Cells with Anti-progastrin Humanized Antibodies as a Potential Treatment for K-RAS-Mutated Colorectal Cancer

artículo científico publicado en 2017

The role of the FOLFIRINOX regimen for advanced pancreatic cancer.

artículo científico publicado en 2013

The value of tumor markers in digestive oncology

artículo científico publicado en 1989

Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial

artículo científico publicado en 2018

Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma

artículo científico publicado en 2010

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil and cisplatin.

artículo científico publicado en 2002

Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases.

artículo científico publicado en 2007

Tumour–stroma interactions in pancreatic ductal adenocarcinoma: Rationale and current evidence for new therapeutic strategies ⬇️

artículo científico publicado el 9 de julio de 2013

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

scientific article published on 01 January 1996

UGT1A1 Polymorphism Can Predict Hematologic Toxicity in Patients Treated with Irinotecan

article

Validation of an appropriate reference gene for normalization of reverse transcription-quantitative polymerase chain reaction data from rectal cancer biopsies

artículo científico publicado en 2009

Value of serial carcinoembryonic antigen levels in evaluating the response to chemotherapy in patients with advanced digestive cancers ⬇️

artículo científico publicado el 1 de septiembre de 1998

[A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma]

artículo científico publicado en 2001

[Carcinoma of unknown primary site. Apropos of 100 patients treated at the Montpellier regional center of cancer prevention]

artículo científico publicado en 1998

[Clinical Practice Guidelines 2004. Standards, Options and Recommendations for the management of patient with adenocarcinoma of the stomach: radiotherapy (therapeutic evaluation)]

scientific article published on 01 April 2005

[Clinical practice guidelines: 2004 Standards, Options and Recommendations for the management of patient with adenocarcinoma of the stomach--radiotherapy].

artículo científico publicado en 2004

[Contribution of endorectal ultrasonography in preoperative evaluation for very low rectal cancer]

artículo científico publicado en 2001

[External beam radiation therapy and interstitial brachytherapy in the treatment of anal canal carcinomas: a series of 70 patients]

scientific article published on 01 December 2003

[Generalized ROC criteria in the evaluation of several tumor markers]

scientific article published on 01 September 1999

[Histologic assessment of treatment effect of preoperative chemoradiation in patients presenting with resectable pancreatic adenocarcinoma]

artículo científico publicado en 2010

[Irinotecan for the treatment of metastatic colorectal cancer]

artículo científico publicado en 2006

[Is neoadjuvant chemotherapy necessary in cancer of the stomach?]

artículo científico publicado en 1995

[Management of colorectal liver metastases after induction treatment. The pathologist's role in 2011]

artículo científico publicado en 2011

[Neoadjuvant treatment of operable esophageal cancers]

scientific article published on 01 October 1999

[Proctectomy and colo-anal anastomosis after high-dose irradiation of cancers of the lower third of the rectum. Functional and oncological results]

artículo científico publicado en 1994

[Prognostic factors of hepatocellular carcinoma: a multivariate analysis in 113 patients]

artículo científico publicado en 1995

[Recommendations for clinical practice: management of stomach adenocarcinoma]

scientific article published on 01 February 2006

[Severe ischemic hepatitis after taking cibenzoline]

artículo científico publicado en 1991

[Should cases of hepatocellular carcinoma be discussed by non-specialized multidisciplinary team meetings?]

artículo científico publicado en 2014

[Stomach adenocarcinomas: comparison between CA 19-9 and carcinoembryonic antigen for the diagnosis of recurrences after surgical treatment]

scientific article published on 01 January 1992

[Therapeutic management of hepatic metastases from colorectal cancers]

scientific article published on 01 March 2003

[Update on gastroenterology]

artículo científico publicado en 2000

[Update on gastroenterology]

artículo científico publicado en 1998

[Vascular hepatic injury following neoadjuvant treatment for a cardial adenocarcinoma]

scientific article published on 01 April 2006

[What can be done for digestive cancer in 1999? Recommendations of the French Foundation of Digestive Cancer (1st Part)]

artículo científico publicado en 1999

[What can be done for patients with digestive cancer in 1999? Guidelines of the French Foundation of Digestive Cancerology (2nd part)]

artículo científico publicado en 1999

p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis.

artículo científico publicado en 2005

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda